プレフィルドシリンジ：世界市場

世界のプレフィルドシリンジの市場規模は、2024年の145億米ドルから、予測期間中は9.5%のCAGRで推移し、2029年末には228億米ドルの規模に成長すると予測されています。

ガラス製プレフィルドシリンジの部門は、2024年の110億米ドルから、同期間中は9.8%のCAGRで推移し、2029年末には175億米ドルに達すると予測されています。プラスチック製プレフィルドシリンジの部門は、2024年の35億米ドルから、CAGR 8.6%で推移し、2029年末には53億米ドルに達すると予測されています。

当レポートでは、世界のプレフィルドシリンジの市場を調査し、市場概要、法規制・償還環境、製品パイプライン、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場概要

第2章 市場概要

• 概要
• ポーターのファイブフォース分析
• 業界における競争力

第3章 市場力学

• 市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会

第4章 規制と保険償還の情勢

• 規制シナリオ
• 米国
• 欧州連合
• 日本
• 中国
• 償還情勢

第5章 プレフィルドシリンジの製品パイプライン

• 概要

第6章 市場セグメンテーション分析

• セグメンテーションの内訳
• 世界のプレフィルドシリンジ市場：材質別
• 世界市場の規模・予測
• ガラス
• プラスチック
• 世界のプレフィルドシリンジ市場：設計別
• 世界市場の規模・予測
• シングルチャンバープレフィルドシリンジ
• デュアルチャンバープレフィルドシリンジ
• カスタマイズプレフィルドシリンジ
• 世界のプレフィルドシリンジ市場：治療区分別
• 世界市場の規模・予測
• 低分子
• モノクローナル抗体
• ワクチン
• その他
• 世界のプレフィルドシリンジ市場：用途別
• 世界市場の規模・予測
• 糖尿病
• 癌
• 感染症
• その他
• 地理的内訳
• 世界のプレフィルドシリンジ市場：地域別
• 世界市場の規模・予測
• 北米
• 欧州
• アジア太平洋
• その他の地域

第7章 競合情報

• 競合情勢

第8章 プレフィルドシリンジの持続可能性：ESGの観点

• ESG：イントロダクション
• プレフィルドシリンジ市場における持続可能性
• 環境への影響
• 社会的責任
• ガバナンス

第9章 付録：世界のプレフィルドシリンジ市場

• 調査手法
• 略語
• 出典
• 企業プロファイル
• ARTE CORP.
• BAXTER
• BD
• F. HOFFMANN-LA ROCHE LTD.
• GERRESHEIMER AG
• HASELMEIER
• NIPRO
• SHL MEDICAL AG
• STEVANATO GROUP
• YPSOMED

List of Tables

• Summary Table : Global Market for Prefilled Syringes, by Material, Through 2029
• Table 1 : Porter's Five Forces Analysis: Prefilled Syringes Market
• Table 2 : Global Diabetes Prevalence, Estimates and Projections, 2019-2045
• Table 3 : Global Prevalence of Multiple Sclerosis, by Region, 2013 and 2020
• Table 4 : Global Population Growth, by Age Group, Through 2050
• Table 5 : Product Pipeline for Prefilled Syringes
• Table 6 : Global Market for Prefilled Syringes, by Material, Through 2029
• Table 7 : Global Market for Glass Prefilled Syringes, by Region, Through 2029
• Table 8 : Global Market for Plastic Prefilled Syringes, by Region, Through 2029
• Table 9 : Global Market for Prefilled Syringes, by Design, Through 2029
• Table 10 : Global Market for Single-Chamber Prefilled Syringes, by Region, Through 2029
• Table 11 : Global Market for Dual-Chamber Prefilled Syringes, by Region, Through 2029
• Table 12 : Global Market for Customized Prefilled Syringes, by Region, Through 2029
• Table 13 : Global Market for Prefilled Syringes, by Therapeutics, Through 2029
• Table 14 : Global Market for Small Molecules, by Region, Through 2029
• Table 15 : Global Market for Monoclonal Antibodies, by Region, Through 2029
• Table 16 : Global Market for Vaccines, by Region, Through 2029
• Table 17 : Global Market for Other Therapeutics, by Region, Through 2029
• Table 18 : Global Market for Prefilled Syringes, by Application, Through 2029
• Table 19 : Global Market for Prefilled Syringes for Diabetes, by Region, Through 2029
• Table 20 : Global Market for Prefilled Syringes for Cancer, by Region, Through 2029
• Table 21 : Global HIV Epidemic, by Age Group, 2021
• Table 22 : Global Market for Prefilled Syringes for Infectious Diseases, by Region, Through 2029
• Table 23 : Global Market for Prefilled Syringes for Other Disease Treatments, by Region, Through 2029
• Table 24 : Global Market for Prefilled Syringes, by Region, Through 2029
• Table 25 : Diabetes Estimates in North America, by Country, 2000-2045
• Table 26 : Influenza Disease Burden in the U.S., by Age Group, 2019 and 2020 Flu Season
• Table 27 : North American Market for Prefilled Syringes, by Material, Through 2029
• Table 28 : North American Market for Prefilled Syringes, by Design, Through 2029
• Table 29 : North American Market for Prefilled Syringes, by Therapeutics, Through 2029
• Table 30 : North American Market for Prefilled Syringes, by Application, Through 2029
• Table 31 : North American Market for Prefilled Syringes, by Country, Through 2029
• Table 32 : Diabetes Estimates for 10 European Countries, 2000-2045
• Table 33 : European Market for Prefilled Syringes, by Material, Through 2029
• Table 34 : European Market for Prefilled Syringes, by Design, Through 2029
• Table 35 : European Market for Prefilled Syringes, by Therapeutics, Through 2029
• Table 36 : European Market for Prefilled Syringes, by Application, Through 2029
• Table 37 : European Market for Prefilled Syringes, by Country, Through 2029
• Table 38 : Diabetes Estimates for the Asia-Pacific Region, by Country, 2000-2045
• Table 39 : Asia-Pacific Market for Prefilled Syringes, by Material, Through 2029
• Table 40 : Asia-Pacific Market for Prefilled Syringes, by Design, Through 2029
• Table 41 : Asia-Pacific Market for Prefilled Syringes, by Therapeutics, Through 2029
• Table 42 : Asia-Pacific Market for Prefilled Syringes, by Application, Through 2029
• Table 43 : Asia-Pacific Market for Prefilled Syringes, by Country, Through 2029
• Table 44 : Diabetes Estimates in the RoW, by Country, 2000-2045
• Table 45 : Estimation of New Cancer Cases in Africa, by Cancer Type, 2020 and 2024
• Table 46 : RoW Market for Prefilled Syringes, by Material, Through 2029
• Table 47 : RoW Market for Prefilled Syringes, by Design, Through 2029
• Table 48 : RoW Market for Prefilled Syringes, by Therapeutics, Through 2029
• Table 49 : RoW Market for Prefilled Syringes, by Application, Through 2029
• Table 50 : RoW Market for Prefilled Syringes, by Sub-Region, Through 2029
• Table 51 : Abbreviations Used in this Report
• Table 52 : Report Sources
• Table 53 : ARTE Corp.: Company Snapshot
• Table 54 : ARTE Corp.: Product Portfolio
• Table 55 : Baxter: Company Snapshot
• Table 56 : Baxter: Financial Performance, FY 2022 and 2023
• Table 57 : Baxter: Product Portfolio
• Table 58 : BD: Company Snapshot
• Table 59 : BD: Financial Performance, FY 2022 and 2023
• Table 60 : BD: Product Portfolio
• Table 61 : BD: News/Key Developments, 2021 and 2022
• Table 62 : F. Hoffmann-La Roche Ltd.: Company Snapshot
• Table 63 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
• Table 64 : F. Hoffmann-La Roche Ltd: Product Portfolio
• Table 65 : Gerresheimer AG: Company Snapshot
• Table 66 : Gerresheimer AG: Financial Performance, FY 2022 and 2023
• Table 67 : Gerresheimer AG: Product Portfolio
• Table 68 : Haselmeier: Company Snapshot
• Table 69 : Haselmeier: Product Portfolio
• Table 70 : Haselmeier: News/Key Developments, 2024
• Table 71 : Nipro: Company Snapshot
• Table 72 : Nipro: Financial Performance, FY 2022 and 2023
• Table 73 : Nipro: Product Portfolio
• Table 74 : SHL Medical AG: Company Snapshot
• Table 75 : SHL Medical AG: Product Portfolio
• Table 76 : SHL Medical AG: News/Key Developments, 2024
• Table 77 : Stevanato Group: Company Snapshot
• Table 78 : Stevanato Group: Financial Performance, FY 2022 and 2023
• Table 79 : Stevanato Group: Product Portfolio
• Table 80 : Stevanato Group: News/Key Developments, 2023
• Table 81 : Ypsomed: Company Snapshot
• Table 82 : Ypsomed: Financial Performance, FY 2022 and 2023
• Table 83 : Ypsomed: Product Portfolio

List of Figures

• Summary Figure : Global Market for Prefilled Syringes, by Material, 2021-2029
• Figure 1 : Prefilled Syringes: Market Dynamics
• Figure 2 : Distribution Share of the Five Most Frequent Cancers in Women, 2022
• Figure 3 : Distribution Share of the Five Most Frequent Cancers in Men, 2022
• Figure 4 : Share of Population Age 65 and Older in G7 Countries, 2021
• Figure 5 : Global Shares of Population 65 and Older, by Region, 2016 and 2050
• Figure 6 : Global Market for Prefilled Syringes, by Material, 2021-2029
• Figure 7 : Global Market for Prefilled Syringes, by Design, 2021-2029
• Figure 8 : Global Market for Prefilled Syringes, by Therapeutics, 2021-2029
• Figure 9 : Global Market for Prefilled Syringes, by Application, 2021-2029
• Figure 10 : Global Market for Prefilled Syringes, by Region, 2021-2029
• Figure 11 : Distribution Share of Cancer Diagnoses in Europe, by Gender, 2020
• Figure 12 : Global Market Shares for Prefilled Syringes, by Company, 2023
• Figure 13 : Pillars of ESG
• Figure 14 : Advantages of ESG for Companies
• Figure 15 : Global ESG-Adoption Level Across All Industries, 2021 and 2022
• Figure 16 : Baxter: Revenue Share, by Country/Region, FY 2023
• Figure 17 : BD: Revenue Share, by Business Unit, FY 2023
• Figure 18 : BD: Revenue Share, by Country/Region, FY 2023
• Figure 19 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
• Figure 20 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
• Figure 21 : Gerresheimer AG: Revenue Share, by Business Unit, FY 2023
• Figure 22 : Gerresheimer AG: Revenue Share, by Country/Region, FY 2023
• Figure 23 : Nipro: Revenue Share, by Business Unit, FY 2023
• Figure 24 : Nipro: Revenue Share, by Country/Region, FY 2023
• Figure 25 : Stevanato Group: Revenue Share, by Business Unit, FY 2023
• Figure 26 : Stevanato Group: Revenue Share, by Country/Region, FY 2023
• Figure 27 : Ypsomed: Revenue Share, by Business Unit, FY 2023
• Figure 28 : Ypsomed: Revenue Share, by Country/Region, FY 2023

The global market for prefilled syringes is expected to grow from $14.5 billion in 2024 and is projected to reach $22.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2024 to 2029.

The global market for glass prefilled syringes is expected to grow from $11.0 billion in 2024 and is projected to reach $17.5 billion by the end of 2029, at a CAGR of 9.8% during the forecast period of 2024 to 2029.

The global market for plastic prefilled syringes is expected to grow from $3.5 billion in 2024 and is projected to reach $5.3 billion by the end of 2029, at a CAGR of 8.6% during the forecast period of 2024 to 2029.

Report Scope

The current report provides detailed information on the market for prefilled syringes. This report analyzes the market trends of prefilled syringes with data from 2023, estimates from 2024, projections of compound annual growth rates (CAGRs) through 2029 (forecast period 2024 to 2029) and regional markets for prefilled syringes. This report will highlight prefilled syringes' current and future market potential and a detailed competitive environment analysis. The recent report will cover regulatory scenarios, drivers, restraints and opportunities. The report also covers market projections for 2029 and the market share for key players.

The market scope in this report is segmented into material, type, design and therapeutics. Based on materials, the report covers glass-based and polymer-based prefilled syringes. The market breakdown by type includes conventional and safety-prefilled syringes. The market is segmented based on design into single-chamber prefilled syringes, dual-chamber and customized prefilled syringes. The report reviews small molecules, heparins, vaccines and all other biologics in the therapeutics segment. It reviews the main prefilled syringe applications, which include arthritis, diabetes, cancer and others.

The market has been segmented into significant geographies, including North America, Europe, Asia-Pacific and other world regions. The regional segment will cover a detailed analysis of major countries, including the U.S., Germany, the U.K., France, Japan, China and India. The market value is estimated for 2023, with forecasts for 2024 and 2029.

Report Includes

• 55 data tables and 29 additional tables
• An updated review of the global markets for prefilled syringes
• Analysis of global market trends, featuring historical revenue data for 2021-2023, estimated figures for 2024, forecasts for 2029, and projections of compound annual growth rates (CAGRs) through 2029
• Evaluation of the current market's size and revenue growth prospects specific to prefilled syringes, along with a market share analysis by material, application, design, therapeutics, and geographic region
• In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market
• Assessment of major market drivers and opportunities estimating current and future demand for prefilled syringes, and key enabling technologies, and COVID-19 impact on the prefilled syringes
• Discussion of key technology developments, latest trends, and other influential factors
• Coverage of upcoming market opportunities and areas of focus to forecast this market into various segments and sub-segments
• Insight into recent industry structure, current competitive scenario, R&D activities, and regulatory and legislative issues currently focused on medical industry
• An analysis of key patents
• Profiles of the leading players, including Becton Dickinson and Co., Baxter, Gerresheimer AG, Schott Pharma AG & Co. KGaA, and West Pharmaceuticals

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of the Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Porter's Five Forces Analysis
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential for New Entrants
• Threat of Substitutes
• Competitiveness in the Industry

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities

Chapter 4 Regulatory and Reimbursement Landscape

• Regulatory Scenario
• U.S.
• European Union
• Japan
• China
• Reimbursement Landscape

Chapter 5 Product Pipeline for Prefilled Syringes

• Overview

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Global Market for Prefilled Syringes, by Material
• Global Market Size and Forecast
• Glass Prefilled Syringes
• Plastic Prefilled Syringes
• Global Market for Prefilled Syringes, by Design
• Global Market Size and Forecast
• Single-Chamber Prefilled Syringes
• Dual-Chamber Prefilled Syringes
• Customized Prefilled Syringes
• Global Market for Prefilled Syringes, by Therapeutics
• Global Market Size and Forecast
• Small Molecules
• Monoclonal Antibodies
• Vaccines
• Other Therapeutics
• Global Market for Prefilled Syringes, by Application
• Global Market Size and Forecast
• Diabetes
• Cancer
• Infectious Diseases
• Other Applications
• Geographic Breakdown
• Global Market for Prefilled Syringes, by Region
• Global Market Size and Forecast
• North America
• Europe
• Asia-Pacific
• Rest of World

Chapter 7 Competitive Intelligence

• Competitive Landscape

Chapter 8 Sustainability in Prefilled Syringes: An ESG Perspective

• Introduction to ESG
• Sustainability in the Prefilled Syringes Market
• Environmental Impact
• Social Responsibility
• Governance

Chapter 9 Appendix: Global Prefilled Syringes Market

• Methodology
• Abbreviations
• Sources
• Company Profiles
• ARTE CORP.
• BAXTER
• BD
• F. HOFFMANN-LA ROCHE LTD.
• GERRESHEIMER AG
• HASELMEIER
• NIPRO
• SHL MEDICAL AG
• STEVANATO GROUP
• YPSOMED